Literature DB >> 7132245

Effects of histamine on the circulatory system.

D A Owen, C A Harvey, M J Boyce.   

Abstract

Experiments have been made in anaesthetised cats and dogs and in healthy, human volunteers to compare the changes in blood pressure and heart rate during systemic administration of histamine. Histamine, 1 x 10(-9) to 1 x 10(-7) mol/kg/min, lowered blood pressure in a similar dose-dependent fashion in all three species. In man and the cat this was accompanied by clear dose-dependent tachycardia whereas in the dog heart rate changes were minimal. Pharmacological analysis of the depressor responses to histamine in all three species and the reduction in total peripheral resistance in the cat and dog showed that the immediate responses to histamine in all three species involved H1-receptors and that sustained responses involved H2-receptors. Abolition of responses to histamine throughout infusions required H1-and H2-receptor blockade. Histamine antagonists, used in doses which cause abolition of cardiovascular responses to large doses of histamine, do not cause any significant change in the resting cardiovascular system.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7132245     DOI: 10.1007/bf01716957

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  6 in total

1.  An analysis of the depressor responses to histamine in the cat and dog: involvement of both H1- and H2-receptors.

Authors:  J W Black; D A Owen; M E Parsons
Journal:  Br J Pharmacol       Date:  1975-07       Impact factor: 8.739

2.  Histamine-induced changes in heart rate in anaesthetized cats [proceedings].

Authors:  D A Owen
Journal:  Br J Pharmacol       Date:  1977-06       Impact factor: 8.739

3.  Tissue blood flow and distribution of cardiac output in cats: changes caused by intravenous infusions of histamine and histamine receptor agonists.

Authors:  B M Johnston; D A Owen
Journal:  Br J Pharmacol       Date:  1977-06       Impact factor: 8.739

Review 4.  Histamine receptors in the cardiovascular.

Authors:  D A Owen
Journal:  Gen Pharmacol       Date:  1977

5.  The effects of histamine on the working kitten heart in vitro: comparison with the effects of noradrenaline [proceedings].

Authors:  S B Flynn; R W Gristwood; D A Owen
Journal:  J Physiol       Date:  1979-04       Impact factor: 5.182

6.  Effects of histamine on human isolated heart muscle: comparison with effects of noradrenaline.

Authors:  R W Gristwood; J C Lincoln; D A Owen
Journal:  J Pharm Pharmacol       Date:  1980-02       Impact factor: 3.765

  6 in total
  9 in total

Review 1.  Biological effects of histamine: an overview.

Authors:  F L Pearce
Journal:  Agents Actions       Date:  1991-05

2.  Effects of histamine on atrial and ventricular contractility in the canine isovolumic heart.

Authors:  H Vidrio; D V Priola
Journal:  Agents Actions       Date:  1990-03

3.  Cardiovascular studies with SK&F 93319, an antagonist of histamine at both H1- and H2-receptors.

Authors:  C A Harvey; D A Owen
Journal:  Br J Pharmacol       Date:  1984-10       Impact factor: 8.739

4.  Allergy, anaphylaxis and anaesthesia.

Authors:  D E Withington
Journal:  Can J Anaesth       Date:  1994-12       Impact factor: 5.063

5.  The basis of the histamine assay in human skin: II. Wheal formation.

Authors:  C Carey; M Clark; J A Lopez-Gil; D W Vere
Journal:  Br J Clin Pharmacol       Date:  1993-07       Impact factor: 4.335

6.  Pharmacological characterisation of cardiovascular histamine receptors in man in vivo.

Authors:  M J Boyce
Journal:  Klin Wochenschr       Date:  1982-09-01

7.  Plasma histamine and hemodynamic responses following administration of nalbuphine and morphine.

Authors:  S M Muldoon; M A Donlon; R Todd; E A Helgeson; W Freas
Journal:  Agents Actions       Date:  1984-10

8.  Temporal responses of cutaneous blood flow and plasma catecholamine concentrations to histamine H1- or H2-receptor stimulation in man.

Authors:  U Knigge; B Alsbjørn; B Thuesen; O Siemssen; P M Christiansen
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

9.  Heparin-binding motif mutations of human diamine oxidase allow the development of a first-in-class histamine-degrading biopharmaceutical.

Authors:  Elisabeth Gludovacz; Kornelia Schuetzenberger; Marlene Resch; Katharina Tillmann; Karin Petroczi; Markus Schosserer; Sigrid Vondra; Serhii Vakal; Gerald Klanert; Jürgen Pollheimer; Tiina A Salminen; Bernd Jilma; Nicole Borth; Thomas Boehm
Journal:  Elife       Date:  2021-09-03       Impact factor: 8.140

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.